Pulmonary emphysema was induced in rats by a single intratracheal instillation of pancreatic elastase. The short-term effects of elastase instillation on basement membrane components were evaluated using immunohistochemical and biochemical methods.
The connective tissue of the lung parenchyma plays an important role in the functioning of the respiratory system. Alterations in the connective tissue skeleton are believed to be important in several chronic lung diseases, such as emphysema and fibrosis [1, 2] . Major compo nents of lung extracellular matrix are elastin, collagen and proteoglycans (PGs). PGs consist of a core protein, to which one or more glycosaminoglycan (GAG) chains are covalently attached. GAGs are polysaccharides which are strongly negatively-charged due to an abundance of carboxylic and/or sulphate groups. In the alveolar wall, two types of PGs are predominantly present: decorin and perlecan. Decorin is a small dermatan sulphate (DS) proteoglycan which is associated with collagen fibrils [3] [4] [5] [6] , and perlecan is a heparan sulphate proteoglycan (HSPG) present in basement membranes [6] [7] [8] [9] .
The predominant theory on the pathogenesis of emphy sema is the protease/antiprotease concept [10] [11] [12] , This concept emanates from a relative excess of proteases (elastases), due to an increase of proteases and/or a de crease of protease inhibitors. An excess of proteases leads to the degradation of the connective tissue skeleton and ultimately to emphysema. One has almost exclusively focused on elastin as the target molecule for proteases, in part because the most studied animal model for emphysema is elastase-induced emphysema. Elastase, however, is also capable of degrading a number of other proteins, including PGs, fibronectin and some types of collagen in vitro [13, 14] . Digestion of PGs may be of particular importance, since: 1) PGs are involved in fib-rillogenesis of collagen and elastin, and can modulate their mechanical characteristics [3, 4] ; 2) PGs interact with and modulate a number of molecules, including growth factors and extracellular matrix molecules [15] [16] [17] [18] [19] [20] [21] ; and 3) GAGs can act as powerful protease inhibi tors, e.g. for leucocyte elastase and cathepsin G [22] [23] [24] . In addition, the close association of PGs with structural elements in the alveolar wall (e.g. basement membranes, collagen fibrils and elastin fibres) indicates a protective role [6, [25] [26] [27] [28] .
In this respect, we studied the effects of an emphysemainducing dose of pancreatic elastase in rats on perlecan (the core protein as well as the heparan sulphate (HS) side-chains) and on other extracellular matrix compo nents of the alveolar wall by immunohistochemical and biochemical methods. Additionally, we investigated the excretion of GAG into the urine following elastase treat ment.
Material and methods
1,9-Dimethylmethylene blue (80% pure) was purchased from Aldrich Chemical Co., Bomem, Belgium; Universal Gel/8 1% agarose gels from Ciba-Corning GmbH, Femwald, Germany; Aquamount from BDH Ltd, Poole UK; halothane from Apharmo, Arnhem, The Netherlands; pentobarbitol (Narcovet) from ICI-Farma, Rotterdam, The Netherlands; diethylaminoethyl (DEAE)-Sepharose Fast Flow from Pharmacia, Uppsala, Sweden; Azure A, Tween-20, whale cartilage chondroitin 4-sulphate, bovine kidney HS, porcine pancreatic elastase, bovine serum albumin (BSA), fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobulin G (IgG), FTTCconjugated goat anti-mouse immunoglobulin M (IgM) and affinity purified rabbit anti-laminin IgG from Sig ma Inc., St. Louis, MO, USA; tetra-methylrhodamine isothiocyanate (TRITC)-conjugated goat anti-mouse Ig and FITC^conjugated donkey anti-goat IgG from Nordic Im m unological Laboratory, Capistrano Beach, CA, USA; affinity purified goat anti-human type IV collagen anti bodies from Southern Biotechnology Ass, Inc., Birmingham, AL, USA; affinity purified rabbit anti-human fibronectin IgG from Dako, Glostrup, Denmark. Rabbit anti-basement membrane HSPG and m onoclonal mouse anti-HS (JM403) antibody were obtained and characterized as described pre viously [9, 29] ,
[35S]GAGs (specific activity 6.105 Bq-^tg1 GAG) were obtained from rats injected twice i.p. with 37,000 Bq Na235S04-g'1 body weight with a 4 h time span between each injection. Four hours after the second injection, the rats were sacrificed and the soft tissues (i.e. liver, kid ney, intestine etc.) removed. GAGs were extracted by alkaline borohydride.
Animal accommodation
Animals were accommodated in groups of three and fed ad libitum. For urine collection, animals were ac commodated separately in metabolic cages. To avoid stress factors, animals were habituated to these cages for 7 days before treatment.
Induction o f pulmonary emphysema
Male Wistar rats (weight 200±10 g) were anaesthetized with 3% halothane, intubated and artificially ventilated according to M a u d e r ly [30] . Rats were hyperventilat ed, to stop intrinsic breathing for a few seconds, and were instilled during this time span with 0.2 IU pancre atic elastase-g'1 body weight in 0.5 ml saline. Control animals were instilled with 0.5 ml saline. After instil lation, rats were ventilated until they awoke.
Histology
Animals were sacrificed by an overdose of pentobar bital injected i,pt For morphometric studies, lungs were dissected and fixed with 2% glutaraldehyde in 150 mmol-/ 1 phosphate buffer (pH 7.2), administered through a polyethylene catheter inserted into the trachea at a pressure of 25 cm H20. After 30 min, lungs were fixed for an additonal 24 h in 2% gluteraldehyde, dehy drated and embedded in paraffin. Tissue sections (6 |im) were contrasted using the trichrome staining of G o ld n er [31] . To assess the degree of emphysema, the mean lin ear intercept was determined using a Mop-videoplan image analyser (Kontron GmbH, Eching, München, Germany). Images of tissue sections were projected on a digitization tablet on which a line raster was applied. Of each lung, a total of 400 intercepts, derived from two sections, were measured.
For immunofluorescence studies, lungs were dissected, and inflated through a polyethylene catheter inserted into the trachea with phosphate-buffered saline (PBS) at a pressure of 25 cm H20. PBS-filled lungs were frozen in liquid nitrogen and stored at -70°C. Cryosections (6 \im) were stored at -70°C. Cryosections were rehydrat ed for 10 min in PBS, containing 1% BSA. Antibodies were applied for 1.5 h in PBS containing 1% BSA. After each antibody, incubation sections were washed in PBS (3x5 min). Anti-HS antibodies and all second ary antibodies were used at a dilution of 1:100. All other antibodies were used at 1:50, Double staining was performed using fluorescein-and rhodamine-labelled secondary antibodies. Sections were embedded in aquamount and examined on a Zeiss axioskop photomicro scope (Carl Zeiss, Oberkochen, Germany). Observations were made by two blinded observers. A "strong1 ' decrease was defined by large areas in the section showing no specific antibody staining. "Weak" was defined by some small areas in the section which showed a reduced immunostaining. "Moderate" was defined as a moder ate number of areas (between strong and weak) show ing a clear, but not complete, absence of staining.
Purification of urinary glycosaminoglycans
Rat urine was collected one day before elastase in stillation, then daily for 9 days and finally on Day 19 post instillation. GAGs were purified from urine by anion exchange chromatography. Urine was centrifuged at 2,000xg for 10 min (at 4°C), and 20 ml of the super natant was diluted to 50 ml by adding 10 mmol-/*1 Tris-HCl (pH 6.8) . The diluted samples were loaded onto a column of 5x0.5 cm containing 0.5 ml DEAE-Sepharose Fast Flow. After an initial wash with 3 ml 0.2 mol*/'1 NaCl/10 mmol*/-1 Tris-HCl (pH 6.8), GAGs were eluted with 4 ml 2 mol-/-1 NaCl/10 mmol-/'1 Tris-HCl (pH 6.8) . Recovery of GAGs was monitored by adding 9.105 Bq [35S]GAG to the urine, and was between 72-101%.
Extraction o f lung glycosaminoglycans
GAGs were extracted according to a modified method of H offm ann [32] , Pleura, large airways and blood ves sels were removed. The remaining tissue was defatted in 20 vol. acetone at -20°C for 16 h, followed by extrac tion with 20 vol. ether/methanol (1:1) at 4°C for 24 h. The material was dried, pulverized with a glass rod and suspended in 40 vol. (w/v) of 0.75 mol-/*1 NaOH/lO mmol-/1 NaBH4. After 1 h at 73°C, the mixture was neutralized with 6 mol*/'1 HC1 and 100% (w/v) trichlo roacetic acid was added to a final concentration of 6%. After 1 h at 4°C, and centrifugation (15 min, 2,000x g, 4°C), the pellet was dissolved in 0.1 mol*/-1 NaOH. The protein concentration was determined according to L ow ry et a l [33] . To the supernatant, 5 vol. of ethanol (100%) was added and after 16 h at -20°C the mix ture was centrifuged (30 min, 15,000xg, 4°C) . The precipitated GAGs were dried and dissolved in de mineralized water. GAGs were quantified using the 1,9dimethylmethylene blue (DMMB) assay (see below).
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Quantification o f sulphated glycosaminoglycans
The content of sulphated GAGs was determined using the DMMB assay of F a r n d a le and co-workers [34, 35] . To 100 |il sample (urine or lung extract) 2.5 ml of DMMB reagent was added and the absorbance at 525 nm was measured directly. The DMMB reagent consists of 48 jimol-/'1 DMMB (initially 48 nmol DMMB was dissol ved in 5 ml 96% ethanol), 42 mmoW*1 glycine and 42 mmol-/-1 NaCl, adjusted to pH 3.0 with 1 mol*/*1 HCL Chondroitin 4-sulphate was taken as a standard and in cluded within each series of assays. For calculations we used second order regression analysis.
Quantification o f urinary heparan sulphate content
Urinary HS content was determined by a nonequilib rium inhibition enzyme-linked immunosorbent assay (ELISA). To 100 ^1 sample 100 |xl anti-HS (JM403) (dilution 1/40,000 in Tris-buffered saline (pH 7.2) con taining 0.1% Tween-20 (TBST) and 1% BS A) was added. After 16 h at 4°C, 100 |il of this mixture was transferred to a HS-coated microtitre plate, and free anti-HS anti bodies were allowed to bind to the coated HS for 2 h. The plate was washed with TBST and 100 pi alkaline phosphatase conjugated anti-mouse Ig, at a dilution of 1/2,000 in TBST/BSA was added. After 1 h, the plates were washed with TBST and alkaline phosphatase was detected using 1 mg-mH dinitrophenyl phosphate in 1 mol*/-1 diethanolamine (pH 9.8) containing 50 mmol-/-1 MgCL,. Absorbance was measured at 405 nm. Bovine kidney HS was taken as a standard within each series of assays.
Characterization o f urinary glycosaminoglycans
Purified urinary GAGs were separated on agarose gel using 0.1 mol*/'1 barium acetate (pH 5.0) as electrophor esis buffer. GAGs were visualized using a combined azure A silver-staining [36] .
Creatinine assay
Creatinine was measured using the alkaline picrate method, based on the Jaffe reaction (Sigma, procedure No. 555).
Statistical analysis
Intergroup comparison was calculated using Student's t-test. Correlation analysis was performed using Pearson's product moment correlation test [37] . All values are given as mean±sEM. Data were normally distributed. day after instillation 
Results
General histology
Three hours after intratracheal instillation of porcine pancreatic elastase, we observed an infiltration of in flammatory cells into the lung accompanied by haemor rhages and pulmonary oedema, indicating acute lung injury. This stage persisted for about 3 days. Lung mor phology returned to normal after 5-7 days. Two weeks after elastase treatment the first emphysematous lesions could be observed. Forty days after elastase treatment the mean linear intercept was increased to 81.7±2.3 |im (n=17), compared to 58.6±1.2 )xm (n=8) for controls.
Immunofluorescence studies o f basement membrane com ponents
In lung parenchyma, HS is linearly distributed in alve oli in accordance with its presence in basement mem branes ( fig. 1) , Table 1 summarizes the effects of elastase on basement membrane components. Three hours after elastase treatment, large areas of the lung lacked HS staining ( fig. 1A and C) . In some cases, one alveolus was completely devoid of HS, whilst in the adjacent alve olus staining was normal (fig, 1A) . At places where HS staining was reduced or absent, staining for the core pro tein of HSPG was also reduced, although to a lesser extent ( fig. 2A and B) . After 5 days, most HS staining had returned. At all times, staining for type IV colla gen, laminin and fibronectin was normal, even at places where HS staining was absent ( fig. 2C-H) . Attempts to localize elastase using commercial antibodies were un successful. The elastase used was devoid of HS digest ing activity, as was demonstrated by incubation of HS with elastase followed by assaying the molecular mass of HS by polyacrylamide gel electrophoresis (data not shown).
Lung and urinary GAG content after elastase instillation
During the first 3 days after elastase treatment, the con tent of GAGs in lung tissue was significantly decreased (2.8±0.07 (n=8) versus 4.6±0.2 (n=8) |ig GAG-mg-1 protein, for saline-treated rats (pcO.OOOl)). Thereafter, no significant changes could be observed.
The concentration of GAGs in urine was significantly increased during the first 4 days after elastase treatment, with a maximum at Day 1 (fig. 3 ). Agarose gel elec trophoresis of the GAGs shows that in addition to the HS the DS excretion was also markedly increased after elastase treatment, with a maximum at Day 1 ( fig. 4 ). ELISA of purified urinary GAGs displayed a signifi cant increase in HS (JM403 epitope) 1-3 days after elas tase treatment, with a maximum level at Day 3 ( fig. 5 ). The apparent discrepancy between the day of peak level of HS measured by ELISA and of HS determined by agarose electrophoresis may be explained by the specifi city of the JM403 antibody. This antibody recognizes only HS from basement membranes and not HS from other sources, such as those located at the cell surface [29] , which are probably also removed from the alveoli as a result of elastase treatment. Therefore, perhaps the HS at Day 1 (lane 2, fig. 4 ) consisted mainly of non basement HS, not detected by the JM403 antibody. This, however, requires further study.
The extent of emphysema, measured as the increase of mean linear intercept 40 days after induction, was posi tively correlated to the concentration of GAGs in the urine during the first 4 days after induction (the time at which GAG excretion was increased) ( fig. 6 ).
Discussion
The predominant theory on the pathogenesis of em physema emanates from a disturbance of the protease/ antiprotease balance, favouring the proteases [10] [11] [12] . Elastin has been regarded as the target molecule in the extracellular matrix. In pancreatic elastase-induced em physema, elastin breakdown occurs [38] . Elastase, how ever, is an indiscriminate enzyme, capable of the in vitro degradation of many proteins, including proteoglycans, collagen, fibronectin and laminin. Little is known about the in vivo effect of elastase on these molecules. In this study, we have shown that, in particular, proteoglycans are target molecules for instilled elastase in rat lungs. Fibronectin, type IV collagen and laminin were not affec ted, although small changes may have gone undetected using immunohistochemistry. These results are in ac cordance with an electron microscopical study on pan creatic elastase-induced emphysema showing no change in laminin or appearance of the basement membrane, but elimination of HS [39, 40] . The observation that in places where HS staining is absent staining for HSPG core protein is only reduced, can be explained by in complete cleavage of the HSPG core protein. Since all three HS chains are attached to the N-terminus of the protein [41, 42] , one cut at this end of the protein will release all HS chains, whereas a large part of the core protein, and thus most of the epitopes for the polyclonal anti-HSPG antibodies, remain present in the basement membrane.
It has been postulated that proteases can induce em physematous lesions only if they possess elastolytic activity [43] . However, several animal models for emphy sema exist where there is no elastin breakdown, includ ing emphysema induced by CdCl2 [44, 45] , by 90% oxygen [46] , or by collagenase [47] , and genetic emphy sema in the tight-skin mouse [48] . In addition, leuco cyte elastase, implicated in emphysematogenesis in man, has been reported to lack elastolytic activity [49] . There is no consensus on elastin breakdown in human pulmo nary emphysema [50] [51] [52] . We suggest, as an alternative possibility, that degradation of proteoglycans (e.g. by leucocyte elastase) is associated with the onset of the disease.
Proteoglycans are implicated in a number of functions important for the integrity of the extracellular matrix, which is compromised in emphysema. The GAGs are powerful inhibitors of proteases, including leucocyte elastase [20, 22, 53] , and prevent leucocyte elastaseinduced emphysema in mouse and rat [23, 24] . Ultrastructurally, proteoglycans are present around collagen fibrils, elastin fibres and in basement membranes [6, 25, 27, 28] . Removal of proteoglycans associated with elas tin facilitates the digestion of the latter [54] [55] [56] . In addi tion, proteoglycans are involved in the fibrillogenesis of the major fibrillar components, collagen and elastin, and may influence their mechanical characteristics [3, 4, 57] . Proteoglycans, especially HSPGs, bind and modulate growth factors, including basic fibroblast growth factor bFGF), interferon-y, interleukin-8 and transforming growth factor-p [16] [17] [18] [19] [20] . In lung parenchyma, degra dation of HS by heparitinase results in the release of bFGF [58] . Hence, removal of proteoglycans from the alveolar wall, e.g. by proteolysis, may result in a distur bance of the extracellular matrix, which may ultimately lead to emphysematous lesions. Intratracheal instillation of hyaluronidase (which digests some types of GAG) to gether with 60% oxygen results in airspace enlargement after 4 days [59].
The disappearance of HSPG in the lung is accompa nied by an increase of GAGs in the urine. This increase, observed during the first 4 days after elastase instilla tion, is positively correlated with the increase of the mean linear intercept, an indicator for parenchymal des truction, 40 days after instillation. Increase of urinary GAGs may, therefore, be an indicator for tissue destruc tion and may be of value in predicting the long-term outcome of acute tissue destruction (e.g. during exacer bations).
In conclusion, intratracheal instillation of pancreatic elastase in rats results in digestion of proteoglycans but not of other basement membrane components. The con comitant increase in urinary GAGs is positively corre lated with the degree of emphysematous lesions observed after 40 days. The vulnerability of PGs toward proteases may be of importance in the pathogenesis of emphyema.
